4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-22-004143
Chief Medical Officer sold 5,000 shares at an average $35.06 ($175,304)
- Chief Medical Officer acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2022-01-19 | Option exercise | +5,000 | $1.53 | $7,650 | 97,777 | D |
| Pang Phillip Chief Medical Officer | 2022-01-19 | Sale | −2,458 | $34.59 | $85,014 | 95,319 | D |
| Pang Phillip Chief Medical Officer | 2022-01-19 | Sale | −2,542 | $35.52 | $90,290 | 92,777 | D |
| Derivatives | |||||||
| Pang Phillip Chief Medical Officer | 2022-01-19 | Option exercise · Stock Option (Right to Buy) | −5,000 | 62,591 | D | ||
| Open-market sales · 5,000 sh · avg $35.06 · $175,304 | |||||||
Loading xslF345X03/doc4.xml…